These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Antiovulatory effect of ICI 33,828 (methallibure) without affecting prolactin release in normal rats.
    Author: Deis RP, Vermouth NT.
    Journal: Neuroendocrinology; 1974; 13(6):351-6. PubMed ID: 4858373.
    Abstract:
    The acute effect of 1-alpha-methylallylthiocarbamoyl-2-methylthiocarbamoylhydrazine (methall ibure) on the release of luteinizing hormone (LH) and prolactin on the day of proestrus was studied in normal rats. 21 rats received 5 mg methallibure/100 gm body weight the day before proestrus when blood samples were obtained for LH and prolactin determinations. The rats were sacrificed the examined for ova. 8 methallibure-treated rats were injected with 10 following morning (first day of estrus) and the oviducts were mcg LH/100 gm body weight on the day of estrus following blood extraction. Oviducts were examined for ova the next day. The single dose of methallibure blocked LH release in 19 out of 21 rats. The 19 rats had mean LH values of 130.2 ng/ml, highly significant (p less than .0001) when compared with 392.7 ng/ml in the controls. Prolactin release was not affected by methallibure, since the mean prolactin level for treated rats was 166.8 ng/ml and 198.7 ng/ml for the controls. The serum prolactin peak on the afternoon of proestrus was confirmed in 7 normal (31 ng/ml) and in 17 estrous rats (28.3 ng/ml). In 4 treated rats, prolactin levels determined on the day of estrus were markedly higher (61 ng/ml; p less than .0001) than in normal estrous rats. None of the rats which had subnormal LH levels showed spontaneous ovulation. However, the 10 mcg LH/100 gm body weight in previously methallibure-treated rats induced ovulation. The number of ova per rat was similar in the LH treated (9.6) and in the controls (10.6). It is concluded that methallibure prevents ovulation by centrally blocking LH release either without affecting or by stimulating prolactin release.
    [Abstract] [Full Text] [Related] [New Search]